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Abstract
Background: Mesenchymal stem (MS) cells are excellent candidates for cell-based therapeutic strategies to regenerate
injured tissue. Although human MS cells can be isolated from bone marrow and directed to differentiate by means of an
osteogenic pathway, the regulation of cell-fate determination is not well understood. Recent reports identify critical roles for
microRNAs (miRNAs), regulators of gene expression either by inhibiting the translation or by stimulating the degradation of
target mRNAs.
Methodology/Principal Findings: In this study, we employed a library of miRNA inhibitors to evaluate the role of miRNAs in
early osteogenic differentiation of human MS cells. We discovered that miR-148b, -27a and -489 are essential for the
regulation of osteogenesis: miR-27a and miR-489 down-regulate while miR-148b up-regulates differentiation. Modulation of
these miRNAs induced osteogenesis in the absence of other external differentiation cues and restored osteogenic potential
in high passage number human MS cells.
Conclusions/Significance: Overall, we have demonstrated the utility of the functional profiling strategy for unraveling
complex miRNA pathways. Our findings indicate that miRNAs regulate early osteogenic differentiation in human MS cells:
miR-148b, -27a, and -489 were found to play a critical role in osteogenesis.
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Introduction
Human mesenchymal stem cells (hMSC) are non-hematopoietic
stromal cells that exhibit multi-lineage differentiation capacity.
Adult bone marrow-derived hMSC are easily isolated and
expanded in culture. These cells can be differentiated to form a
variety of tissues including bone, cartilage, tendon, adipose and
other tissues [1,2]. Tissue specific differentiation of hMSC is a
multi-stage process where each step is typically associated with
expression of specific markers. In particular, early osteogenesis is
accompanied by an increase in bone-specific alkaline phosphatase
(AP) activity and by induction of specific biomarkers including
SPP1 (osteopontin) among others [3,4]. Despite the progress made
in characterizing hMSC differentiation, the molecular determi-
nants that regulate osteogenesis are not completely understood.
MicroRNAs (miRNAs) modulate gene expression by inhibiting the
translation or promoting the degradation of target mRNAs. To date,
hundreds of human miRNAs have been identified through
experimentation or by in silico analyses [5,6]. Since miRNAs can
regulate more than one target, estimates indicate that they regulate
up to 30 percent of the protein-coding genes in the human genome,
highlighting their importance as regulators of gene expression.
Recent studies indicate that miRNAs are involved in the determi-
nation of various cell fates – neuronal, muscle and others [7–9]. With
regard to hMSC, little is known about the role of miRNAs in
differentiation [10,11] or regulation of osteogenesis [12].
Current methodologies for identifying miRNAs focus on
measuring levels of miRNAs within a cell type. Unfortunately,
expression of miRNAs vary dramatically within cells, often being
limited to just a few copies per cell making detection very difficult
[13]. These assays correlate the presence of a given miRNA with a
specific outcome (i.e. osteogenesis) but fail to identify the role or
target(s) of the miRNA. Alternatively, a functional analysis of
miRNAs’ role in osteogenesis can be obtained by screening a
collection of miRNA inhibitors that modulate the endogenous
levels of miRNAs during osteogensis in hMSCs. In this study, we
found that hsa-miR-148b, -27a and -489 were capable of
regulating osteogenic cell fates. Moreover, modulation of the
miRNA levels induces differentiation in the absence of external
cues and stimulates osteogenesis in over-propagated hMSC. We
performed preliminary studies using siRNA-mediated knockdown
to identify actual miRNA targets from a subset of in silico predicted
candidates. Further studies will help define whether these mRNAs
play direct or indirect roles in the osteogenic pathway. Together,
the data suggests that miRNAs are essential regulators of early
osteogenic differentiation of hMSC.
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It has been reported that antisense inhibition of specific
miRNAs can dramatically affect cellular differentiation [7–9].
To determine if miRNAs regulate hMSC osteogenic differentia-
tion, we conducted a functional miRNA screen. hMSC were
transfected with a library of miRNA inhibitors and subjected to
osteogenic differentiation by incubation in differentiation media.
Early osteogenesis in hMS cells is accompanied by the differential
expression of multiple markers of osteogenic differentiation. One
such example is a significant increase in alkaline phosphatase (AP)
activity making this a convenient marker for osteogenic differen-
tiation [4]. In our experiments a change in AP activity in
transfected cultures was used as a marker of osteogenic
differentiation. Candidate miRNAs were identified as described
in Materials and Methods. Briefly, Z-score values for an AP
activity assay were used to select candidates from the initial
functional miRNA screen. miRNA inhibitors that demonstrated
Z-score values that were two standard deviations (SD) from the
control were selected as hits and were included in follow-up
experiments (Fig. 1a).Of 396 miRNA inhibitors, fifteen were
identified in the primary screen for their effect on differentiation.
Seven inhibitors were subsequently confirmed in independent
experiments (Fig. 1b); six inhibitors (miR-489,-189,-153,-27a,
-133a,-and -486) increased AP activity and one (hsa-miR-148b)
decreased activity in differentiated hMSC. An increase in AP
activity upon inhibition of a miRNA indicates that the miRNA
may be necessary for suppression of differentiation. In contrast, a
decrease in AP activity suggests that the miRNA may be necessary
for stimulation of osteogenesis. To investigate if miRNA activity is
sufficient for regulation of early osteogenic differentiation, we
initiated experiments with miRNA mimics. Change in AP activity
from cells transfected with mimics would indicate that miRNA
activity is sufficient to stimulate osteogenesis. Four of the miRNA
mimics demonstrated no effect on AP activity (Fig. 1b), miR-189,
-153, -133a and -486, suggesting that these miRNAs while
necessary are not sufficient for regulation of early osteogenesis in
hMSC under the effect of external stimuli. Three miRNA mimics,
miR-148b, -27a and -489, had an effect that was opposite to their
respective inhibitors (Fig. 1b). For all three miRNA inhibitors and
mimics, osteogenesis was affected in a concentration dependent
manner (Fig. S1). All together, these findings demonstrate that
these three miRNA are both necessary and sufficient to modulate
early osteogenesis in hMSC: miR-489 and miR-27a down-regulate
and miR-148b up-regulates differentiation.
miR-148b, -27a and -489 were found to be essential for
osteogenesis in our experiments. We hypothesize that their
functions may correlate with the level of expression in hMSC
under propagation or differentiation conditions. To study
expression of these miRNAs that are essential for osteogenesis
we employed RT-PCR-based expression analysis. The analysis
revealed that miR-148b and miR-27a both can be detected in
undifferentiated and differentiated cells (Table S1.) at the level of
tens and hundreds of copies per cell, respectively. For comparison,
miR-16, a miRNA that was reported to be ubiquitously expressed
in thousands of copies per cell [13] was detected at nearly 8000
copies per cell for both undifferentiated and differentiated hMSC
(data not show).
We found that upon osteogenic differentiation, expression of
miR-27a decreases 41% (p-value,0.01) and miR-148b increases
67% (p-value,0.02) (Table S1). Expression of miR-489 was
detected at very low levels in hMSC. Only 0.9 copies per cell were
found in cells harvested under propagation conditions. After
induction of differentiation, expression of miR-489 becomes
almost undetectable, decreasing 10-fold (p-value,0.1) (Table
S1). Overall, this data indicates that miR-148b, -27a and -489
expression levels correlate with their function. In general, miRNAs
that stimulate differentiation demonstrated higher expression in
differentiated cells, and miRNAs that mitigate differentiation
demonstrated lower expression in differentiated cells.
Our study revealed that miR-148b, -27a and -489 play critical
roles in osteogenesis in hMCS. Osteogenesis is only one of several
differentiation pathways that hMSC can undergo. Thus, miRNA
modulation may be either specific or non-specific to osteogenic
differentiation. To test specificity of the effect, we examined the
ability of transfected hMSC to undergo adipogenic differentiation.
Transfection with miR-148b, -27a and -489 inhibitors produced
no change in number of adipocytes in hMSC cultures (Fig. S2).
This demonstrates that modulation of miR-148b, -27a and -489
levels has no effect on hMSC adipogenesis and suggests that the
miRNA effect may be specific.
Osteogenic differentiation of hMSC is achieved by incubating in
the presence of a differentiation cocktail, including dexametha-
Figure 1. Inhibition of miRNAs dramatically affect osteogenic
differentiation of hMSC. (A) Fifteen miRNA inhibitors were selected
in the primary screen for their effect on AP activity in differentiated
hMSC. Data are representative of a single screen performed in triplicate.
(B) Seven inhibitors were confirmed as hits in separate experiments.
miRNA mimics for four miRNAs demonstrated no effect on AP activity,
-miR-189, -153, -133a and -486. For three other miRNAs, miR -148b, -27a
and -489, mimics had an effect that was opposite to one of the
corresponding inhibitors. Data are representative of three independent
experiments performed in triplicate. (mean+/2SD). *, **: Student’s ttest
p value between treated cells and corresponding control group,
*-p ,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0005605.g001
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experiments with differentiated hMSC suggests that the modula-
tion of miR-148b, -27a and -489 may be sufficient for the
induction of osteogenesis. To test this hypothesis, hMSC were
incubated in propagation media lacking differentiation stimuli and
miRNA levels were altered. In these experiments, alteration of the
miRNA levels alone induced osteogenic differentiation of hMSC
in the absence of other differentiation stimuli (Fig. 2, Fig. S3). Cells
transfected with miR-489 inhibitor or miR-148b mimic alone or in
combination demonstrated a drastic increase in total AP activity
and in the number of AP-positive cells (Fig. 2a, Fig.S3). Up-
regulation of another marker of early osteogenic differentiation,
SPP1 (Fig. 2b), was also found in transfected cells. Interestingly,
while inhibitor miR-27a was able to up-regulate osteogenesis in
transfected cells incubated in differentiation media, it demonstrat-
ed very low effect on cells in propagation media (Fig. 2a). Also,
induction of SPP1 expression was found in cells transfected with
miR-27a inhibitor (Fig. 2b). These findings indicate that miR-27a
and -489 may affect both related and unrelated pathways.
hMSC can originate from donors with variable genetic
background and certain donor-to-donor variability has been
reported [14]. Also, human adult stem cells with osteogenic
potential can be derived from various tissues, including adipose
tissue [2]. In our experiments, we found that miRNA modulators
were effective in cells derived from two independent donors, male
and female (Fig. S4a). Furthermore, miRIDIAN miRNA modu-
lators were found to be successful in stimulation of osteogenesis in
adult stem cells derived from adipose tissue (Fig. S4b and S4c).
To generate an amount of material that is necessary for tissue
replacement therapy, hMSC can be subjected to propagation in
vitro. Unfortunately, hMSC that are extensively propagated tend to
loose their differentiation potential [14–16]. In our experiments,
bone marrow hMSC with high passage number demonstrated
decreased basal level of AP activity and poor response to
differentiation media (Fig. 3a). Surprisingly, transfection with
miR-148b mimic, miR-489 or -27a inhibitors were able to rescue
osteogenic potential in hMSC with high passage number.
Transfection with miRNA modulators induced total AP activity
in high passage number hMSC (Fig. 3b, c). Expression of SPP1
was also up-regulated in hMSC with high passage number
transfected with miRNA activity modulators (Fig. S5 a,b).
As determined by the miRanda 3.0 algorithm and L2L gene
ontology tool [17], both miR-27a and -489 target a number of
genes that are related to bone remodeling and skeletal develop-
ment (Table S2). Three genes were present in both gene lists,
AHSG, PEX7 and CHRD. Products of AHSG and CHRD
encode Bone Morphogenetic Protein (BMP) signaling inhibitors
[18,19]. Similarly, PEX7 is a gene which encodes the receptor for
a class of peroxisomal matrix enzymes, critical enzymes in bone
morphogenesis [20]. RT-PCR-based study of gene expression
demonstrated that both CHRD and PEX7 mRNA are present in
hMSC but only PEX7 is regulated by miR-489 and -27a (Fig.
S6a). Expression of AHSG was not detected in hMSC by RT-PCR
(data not shown). We hypothesize that if PEX7 is a key target of
miR-27a and miR-489 then its knockdown may mimic effect of
these miRNAs and inhibit osteogenic differentiation. Experiments
with siRNA-mediated knockdown of PEX7 did not result in a
significant decrease of AP activity in hMSC under differentiation
conditions (Fig. S6b). Thus, while PEX7 still can be a target of
miR-27a and miR-489 it may not mediate effect of these miRNAs
on osteogeneis.
miR-489 and -27a have 80 predicted targets in common (Table
S3). Our preliminary analysis of siRNA mediated knockdown of
target genes that are not related to osteogenesis revealed that some
of these genes may be involved in the regulation of osteogenesis in
hMSC (Fig. 4 and data not shown). While a control siRNA has no
effect on osteogenesis, siRNA-mediated knockdown of GCA
(grancalcin) or SLC22A2 (solute carrier protein) did result in a
significant decrease of AP activity in hMSC under differentiation
conditions (Fig. 4i, and data not shown). Expression of SLC22A2
was not detected by RT-PCR in hMSCs used in our study. In a
contrary, both RT-PCR-based study and immunohistochemistry-
based analysis of gene expression demonstrated that GCA mRNA
is present in hMSC and regulated by miR-489 and -27a (Fig. 4).
Additionally, we found that GCA 39UTR reporter activity is
regulated by miR-489 and -27a (Fig. S7). While further studies are
needed to investigate the possible roles of miR-27a and -489
targets in greater detail, our data suggests that the inhibitory effect
of miR-489 and -27a is, at least in part, mediated by repression of
GCA.
Discussion
Although the biological functions of most miRNA are unknown,
their importance for molecular regulation of differentiation, cell
proliferation, and cell death has been demonstrated [7–9]. By
Figure 2. Adjustment of the miRNAs activity alone induced
osteogenic differentiation of hMSC in the absence of other
differentiation stimuli. Cells transfected with miRNA inhibitors or
mimics alone or in combination, demonstrated drastic increase in total
AP activity (A), and up-regulation of SPP1, another marker of early
ostogenesis (B) . Data are representative of three independent
experiments performed in triplicate. (mean+/2SD). *, **: Student’s ttest
p value between treated cells and corresponding control group,
*-p ,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0005605.g002
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three miRNAs that are critical regulators of early osteogenesis in
hMSC, namely miR-148b, -27a and -489.
The candidate miRNAs, miR-489, -27a and -148b, are
representatives of three miRNA families. Family members are
thought to have similar target specificity [21] and may affect
cellular physiology in a common fashion. In human cells, the miR-
489 family is represented by a single member, miR-489. The miR-
27 family is represented by two members, miR-27a and -27b.
Similarly, family miR-148 is represented by miR-148a and 148b.
Human miR-27a and -27b differ by a single nucleotide at position
19. miR-148a and -148b differ by two nucleotides at positions 7
and 8. We found that the miR-27b inhibitor induces a relatively
small increase in AP activity in hMSC. AP activity for miR-148a
inhibitor treated/transfected cells was extremely variable and fell
into an outlier category (data not shown). Further experiments
demonstrated that miR-148a mimic was able to induce AP activity
in hMSC, but it was at least two-fold less potent than the mimic of
miR-148b (data not shown). Based on these results both miR-27b
and miR-148a were excluded from further study.
Upon differentiation, expression of miR-27a and -148b changed
and correlated with the level of osteogenic differentiation that was
observed at day six. Expression of miR-489 was detected at a very
low level in undifferentiated MS cells and appeared to decrease
even further upon differentiation. Our findings agree with
previously published data on expression of miR-148b and -489.
miR-148b was found among a group of miRNAs that were
associated with osteoblast differentiation, in a particular 3D
substrate [22]. In contrast, miR-489 was found to be down-
regulated under similar conditions [23].
Other groups have reported that miR-26a and miR-125b play
an important role in the regulation of osteogenic differentiation in
human adipose tissue-derived stem cells and in mouse ST2 cell line
respectively [12,24]. In our screening experiments, inhibitors for
both of these miRNAs produced significant variability and were
outliers by our criteria. Further studies will be required to
determine if these two miRNAs play roles in osteogenic
differentiation of human bone marrow MS cells.
miRNAs target a multitude of genes and regulate cellular
physiology through different mechanisms. Both miR-489 and -27a
down-regulated osteogenesis, suggesting the possibility of common
gene targets (Fig. 1b, 2b, Fig. S2). Using miRanda 3.0 an in silico
prediction tool, over 2,000 genes can be predicted as targets for
these miRNAs, with 81 gene targets common for both miRNAs.
Analysis of the predicted gene targets revealed that APL, a gene
encoding liver/bone/kidney-specific alkaline phosphatase, may be
a target for miR-27a but not for miR-489. Similarly, SPP1may be a
target for miR-489 but not for miR-27a. As expected, inhibition of
each miRNA induced both markers, respectively. Interestingly,
inhibition of miR-489 had a stronger effect on AP activity induction
than inhibition of miR-27a. However, inhibition of miR-27a
demonstrated more substantial activation of SPP1 expression in
comparison with inhibition of miR-489. When either APL or SPP1
were down-regulated using siRNAs, there was no effect on the other
gene (data not shown). Together, this data suggests that the two
miRNAs regulate certain osteogenesis-inducing genes which are
likely to be located upstream of APL and SPP1.
Our findings indicate that miR-27a, -489 and -148b may affect
both related and unrelated pathways. Inhibitor of miR-489 was
able to stimulate differentiation in either propagation or
differentiation conditions while inhibitor of miR-27a was active
in the differentiation conditions only. Interestingly, the addition of
i27a to the combination i489+m148b (Fig. 2b) was detrimental for
osteogenic differentiation in cells under propagation conditions
while no change have been expected. One can speculate that
possible explanation of this finding may include a cross-talk
between multidute of direct and indirect targets that are regulated
by all three miRNAs in complex spatio-temporal system of
mNSCs differentiation. All together three miRNAs of interest have
Figure 3. Alteration of the miRNAs activity rescues osteogenic
potential in transfected hMSC with high passage number. (A)
Bone marrow hMSC with high passage number demonstrate a decrease
in basal level of AP activity and poor response to differentiation media.
hMSC were plated in 96-well plates and incubated either in propagation
(P, grey bar) or osteogenic (O, black bar) media for 6 days. Data
normalized to relative AP activity values obtained from passage 21
hMSC incubated in propagation media. (B and C) Transfection with
miRNA inhibitors and mimics restore differentiation in over-propagated
hMSC incubated in propagation (B) or differentiation (C) media. hMSC
propagated for certain number of passages (16, white bar, 18, grey bar
or 21 , black bar) plated in 96-well plates and transfected with inhibitors
and mimics (as indicated, all at 25 nM). Data are representative of three
independent experiments performed in triplicate. (mean+/2SD). *, **:
Student’s ttest p value between treated cells and corresponding control
group, * - p,0.01, ** - p,0.05.
doi:10.1371/journal.pone.0005605.g003
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Further extencive study will be needed to elucidate all possible
interactions between their targets.
In silico analysis of predicted targets followed by siRNA-mediated
knockdown experiments indicated that GCA (grancalcin) is a
regulator of osteogenesis in hMSCs. GCA is a common target for
miR-27a and -489 and its expression is directly regulated by these
miRNAs (Fig. 4). Downregulation of GCA expression using siRNAs
resulted in a drastic decrease in osteogenic differentiation of hMSCs
(Fig. 4). Grancalcin, a product of GCA, is a penta-EF-hand Ca2+-
binding protein [25,26] . While some of the members of the PEF-
hand protein family, calpains, have been described as potent
regulators of differentiation in hMSCs, grancalcin was previously
not associated with ostegenesis [27].
Analysis of over 800 genes that are predicted as targets for miR-
148b (miRanda 3.0, [28,29] identified multiple genes that are
Figure 4. Negative effect of miRNAs, miR-489 and -27a, on osteogenesis in hMSC is, at least in part, mediated by repression of GCA
gene expression. (A–G) Transfection with inhibitors of miR-489 and -27a results in up-regulation of GCA protein expression. (A–F). hMSC were
transfected with control molecule, ic1 (25 nM) or with combination of inhibitors, i489+i27a (12.5 nM each). GCA protein expression was determined
by immunofluorescence as described in Materials and Methods. Cells were stained with Hoechst 33342 (A–C) and GCA specific primary antibody,
followed by a secondary antibody (E,F). Control wells were treated with secondary antibody only and demonstrate no specific staining (D). (G)
Quantitation of GCA immunohystochemistry. Data shown represents three independent transfections, four fields each. (mean+/2SD). ** - Student’s
ttest p value between treated cells and corresponding control group, p,0.05. (H) RT-PCR-based study of gene expression demonstrated that the
expression of GCA mRNA is regulated by miR-489 and -27a. hMSC were transfected with Inhibitor Control molecule 1 (IC1, 25 nM) or with a
combination of inhibitors for miR-27 and -489 (i27a+i489, 12.5 nM each). Transfected cells were incubated for 2 days in propagation media and then
harvested for totat RNA. (I) siRNA-mediated knockdown of GCA (grancalcin) resulted in a significant decrease of AP activity in hMSC under
differentiation conditions. hMSC were transfected with Control siRNA, RUNX2 and GCA siRNA (each at 50 nM). Cells were switched to osteogenic
media 24 hr after transfection and harvested 6 days after the switch. Data shown represents two independent transfection experiments performed in
duplicate (H) or triplicate (I) (mean+/2SD). **: Student’s ttest p value between treated cells and corresponding control group, p,0.05.
doi:10.1371/journal.pone.0005605.g004
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further studies will be required to confirm the role of these genes in
miRNA-mediated regulation of hMSC differentiation.
In conclusion, we have demonstrated the utility of the functional
profiling strategy for unraveling complex pathways. Specifically,
we have begun to characterize the distinct regulatory roles for
three miRNAs in osteogenesis. miR-148b, -27a, and -489 were
found to play a critical role in osteogenesis in human mesenchymal
stem cells. Understanding the complex interplay of miRNAs and
their targets will aid in developing viable cell-based therapeutic
strategies in regenerative medicine.
Materials and Methods
Cell propagation and differentiation
hMSC were purchased from Lonza (Bazel, Switzerland, Lot#
4f1301, and # 6f3674) and ScienCell (Carlsbad, CA , lot #1134).
Cells were propagated using either hMSC propagation media
(Lonza) or DMEM supplemented with 10% FBS (Thermo Fisher
Scientific). Cells maintained in either media demonstrated
comparable proliferation rates and differentiation capacity toward
osteogenic and adipogenic lineages.
Differentiation was induced using specific osteogenic or adipogenic
stimulating media (Lonza) according to protocols provided by cell
supplier. As indicated by the manufacturer, osteogenic differentiation
media was supplemented with dexamethasone, ascorbate and b-
glycerophosphate. Induction media for the adipogenic differentiation
contained dexametasone, IBMX and insulin, and maintenance
media was with insulin only. For osteogenic differentiation, cells were
harvested six days after induction.
Transfection and library screening
Transfection optimization was performed using a siRNA
SMARTpool targeting human PPIB (NM_000942, Thermo
Scientific, Lafayette, CO) complexed with the lipid-based
transfection reagents DharmaFECT 1, 2, 3, or 4. DharmaFECT
1 was selected for all further transfections as it provided over 90%
transfection efficiency in both low and high passage number
hMSC. Transfection of miRNA inhibitors and mimics was
confirmed by the uptake of fluorescently labeled control molecules
miRNA Inhibitor Control 1 and Mimic Control 1 (ThermoFisher
Scientific, Waltham, MA Fig S8) . RUNX2 (NM_001015051,
NM_001024630, NM_004348) siRNA pool and Control Non-
Targeting siRNA pool (Thermo Scientific, Waltham, MA ) were
used to calculate the Z9 factor for the AP activity assay and to
monitor transfection efficiency throughout the whole study. The
Z9 factor for a pair of positive and negative controls (RUNX2 and
Control siRNA pools) for total AP activity was 0.3 or better
indicating that the assay remains robust (data not shown). These
and other siRNA pools (GCA (NM_012198) and SLC22A2
(NM_003058)) were used at the concentration of 50 nM.
miRIDIAN miRNA inhibitors and mimics (Thermo Scientific,
Waltham, MA) were described previously [30] . In brief, these
molecules were designed to target 396 human miRNAs (Sanger
miRBase v 8.0) were chemically synthesized and transfected into
hMSC using optimized transfection conditions. For transfection,
cells were plated into 96-well plates (ThermoFisher Scientific,
Waltham, MA) at a density of 2,500 (osteogenic differentiation) or
10,000 (adipogenic differentiation) cells per well. miRIDIAN
miRNA Inhibitor Control 1 and Mimic Control 1 (IC1 and MC1,
respectively; Thermo Fisher Scientific, Waltham, MA) were used
throughout the study as negative control molecules. IC1 and MC1
target and mimic respectively, cel-mir-67, a C. elegans miRNA
which are expected to have no sequence homology to miRNAs
derived from the human genome.
Preliminary experiments with the IC1 and MC1 control
molecules demonstrated that for both control molecules, 25 nM
was the highest concentration that produced no effect on AP
activity in differentiating hMSC (Fig. S9a). Thus, a concentration
of 25 nM was selected for the majority of experiments with
miRNA inhibitors and mimics. In all experiments, relative AP
activity was normalized to IC1 or MC1 controls for each plate
separately. Change in AP activity in transfected cultures was used
as a measure of osteogenic differentiation to monitor effect of
miRNA inhibitors. Screening experiments were performed in
triplicate and means, standard deviations, and CVs were
determined. Inhibitors with CVs more or equal to 0.5 were
discarded as outliers.
Z-score values for the AP activity assay were used to select hits
in the initial functional miRNA profiling experiments. Z-score was
calculated as follows:
Z ~ x { m ðÞ =s
where: x is a raw score to be standardized, s is the standard
deviation of the population, and m is the mean of the population.
Population was comprised of means from the entire screening
experiment, excluding controls. miRNA inhibitors that demon-
strated Z-score values that were outside of 2SD window were
selected as hits and were subjected to hit validation experiments
(Fig. 1a). For a MIARE compliant version of the miRNA inhibitor
screen data please contact corresponding author at Yuriy.Fedorov
@thermofisher.com.
Differentiation assays
In our experiments, we found that under the effect of exogenous
stimuli, hMSC undergo osteogenic differentiation. By day six
following treatment with differentiation media, total AP activity
increased two to three-fold (Fig. S9b) and the fraction of AP-
positive cells increased up to nine-fold (Fig. S9c). In addition to
induction of AP activity, early osteogenesis is associated with
stimulation of specific biomarker expression, including SPP1, a
gene that encodes osteopontin [3]. By day six, SPP1 increased
more than six-fold over control cells that were maintained in
propagation media (Fig. S9d).
In our experiments, cells were assayed for osteogenic differenti-
ation at day six. Total AP activity was determined by p-nitrophenol
phosphate conversion method using an AP activity kit (BRSC, NY).
Raw AP activity values were normalized to total protein determined
by Advanced Protein Assay (Cytoskeleton, CO). To determine the
fraction of AP-positive cells inthe hMSC cultures, cells werefixed in
4% paraformaldehyde (EM Sciences,Hatfield,PA) and stained with
ELF97 kit (ATCC, MD). SYTO Green (Life Technologies,
Carlsbad, CA) was used as a nuclear counter stain. Adipogenic
differentiation was assayed after incubation in induction media for 6
days and 3 days in maintenance media. Adipogenesis was
determined byOilRedO staining(Sigma,St.Louis,MO)combined
with H33342 nuclear dye (Life Technologies, Carlsbad, CA). Both
ELF97 and Oil Red O images of stained cells were acquired using
an ArrayScan VTi (Thermo Fisher Scientific, Waltham, MA) and
quantified using the Target Activation Bioapplication software tools
(Thermo Fisher Scientific, Waltham, MA).
miRNA expression analysis
The RNeasy Plus kit (Qiagen, Valencia, CA) was used for total
RNA purification. miRNA expression analysis was performed
Functional Profiling of miRNAs
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average yield of 3 pg/cell. The miRNA copy number per cell was
estimated based on standard curves of synthetic miRNAs. Total
RNA was added to RT reaction in an amount of 120 ng.
TaqManH MicroRNA Reverse Transcription Kit (Life Technol-
ogies, Carlsbad, CA) was used for the RT step. Corresponding
TaqManH Human MicroRNA Assays (Life Technologies, Carls-
bad, CA) were used to determine the copy number of miR- 498,
-27a, and -148b. The ubiquitously expressed miRNA, hsa-miR-16
was used as a positive control. Cel-miR-67 was used as a negative
control. Reactions were set up according to the supplier’s protocol.
Additionally, all sets of primers were tested with synthetic RNA
corresponding to the miRNAs. Absolute quantification values
were acquired using the Stratagene Mx3005p.
Predicted miRNA target analysis
miRBase Targets Release Version 2 (Wellcome Trust Sanger
Institute) was used to search for predicted targets. miRanda 3.0
algorithm was used for target prediction. Predicted target lists were
analyzed for association with Gene Ontology (GO) terms using
L2L Microarray Analysis Tool (University of Washington) [17].
Ananlysis of miRNA activity using 39UTR reporter system
The effects of selected synthetic miRNA mimics on endogenous
human 39UTRs were measured using reporter constructs (Switch-
Gear Genomics, Menlo Park, CA). Briefly, 39UTR-reporter
vectors were constructed by cloning UTRs from two known
human UTRs and two random genomic fragments downstream of
a firefly luciferase (luc2P) reporter cassette (Promega, Madison,
WI). Genomic coordinates of the cloned fragments described in
Table S4. Transcription of the hybrid transcripts was driven by the
constitutively active RPL13 promoter on every vector. A control
vector containing no extra UTR sequence and the two vectors
containing random genomic sequence were used to control for
overall signal variation based on the non-specific response of cells
to different treatments.
Transient transfection assays were conducted in HT1080
human fibrosarcoma cells (ATCC, Manassas, VA) in 96-well
plates. Briefly, 6,000 cells per well were seeded in culture medium
for 24 hr before transfection. Next, in each well, 0.15 uL
Dharmafect Duo (Thermo Fisher Scientific, Waltham, MA) was
used to transfect 100 ng of plasmid DNA and either a miRNA
mimic or a non-targeting control according to manufacturer’s
protocol. Mimics and non-targeting controls were added to yield
final concentrations of 12.5 nM. After 24 hours, 100 uL of
Steady-Glo (Promega, Madison, WI) was added into each well,
incubated at room temperature for 30 min, and then signals were
read in a standard plate luminometer (Molecular Devices,
Sunnyvale, CA). Each transfection was conducted and assayed
in triplicate.
After normalizing for between-treatment signal variation, a
Student’s t-test (p,0.05) was used to assess whether the activity of
the cloned UTR fragment was different in the presence of a
miRNA mimic as compared to the non-targeting control. Finally,
a log2 ratio of activity was calculated for miRNA mimic treated/
non-targeting control signals.
Gene expression analysis
PPIB (NM_000942), RUNX2 (NM_001015051,
NM_001024630, NM_004348) and SPP1 (NM_000582, osteo-
pontin) expression was determined using branched DNA assay
(Panomics, Fremont, CA). GAPDH was used as a housekeeping
reference gene for normalization purposes. In all experiments,
relative gene expression was normalized to IC1 or MC1 controls
for each plate separately.
Expression of GCA (NM_012198), SLC22A2 (NM_003058),
PEX7 (NM_000288.3), AHSG (NM_001622), and CHRD
(NM_003741) was determined by qRT-PCR. Corresponding
TaqManH Gene Expression Assays were purchased from Life
Technologies (Carlsbad, CA) - GCA Assay ID Hs00201854_m1,
SLC22A2 Assay ID Hs00533907_m1, PEX7 Assay ID
Hs00165464_m1, AHSG Assay ID Hs00155659_m1, and CHRD
Assay ID Hs00415315_m1. High-Capacity cDNA Reverse
Transcription Kit was used for the cDNA synthesis step. Human
GAPD TaqManH Endogenous Control (NM_002046.3) was used
to determine GAPD expression for analysis of relative expression
of the specific genes. Reactions were set up according to the
supplier’s protocol. The qPCR step and the Ct values that were
used for further analysis were obtained using the Stratagene
Mx3005p.
GCA (NM_012198) protein expression was determined by
immunofluorescence. Cells were fixed day six after transfection
with 4% paraformaldehyde (EM Sciences, Hatfield, PA). Cell
plates were blocked with buffer containing 1% BSA combined
with H33342 nuclear dye (Life Technologies, Carlsbad, CA).
Primary anti-GCA mouse monoclonal antibody (H00025801-
M01) was purchased from Abnova Corporation (Taiwan). The
GCA antibody was diluted 1 to 25 for a final concentration of
40mg/mL. Secondary antibody, Goat Anti-Mouse IgG (H+L)
DyLight 649 conjugated (Thermo Fisher Scientific, Waltham,
MA), was used at a concentration of 2mg/mL, a 1 to 500 dilution.
Images of stained cells were acquired using an ArrayScan VTi
(Thermo Fisher Scientific, Waltham, MA) and quantified using the
Target Activation Bioapplication software tools (Thermo Fisher
Scientific, Waltham, MA).
Statistical Analysis
Student’s t-test was used to evaluate statistical significance.
Supporting Information
Figure S1 Both inhibitors and mimics affect osteogenesis in a
concentration dependent manner. hMSC were transfected with
miRNA inhibitors (A) and mimics (B) as indicated. Transfected
cells were switched to differentiation 24 hr after transfection. AP
activity was measured in hMSCs incubated in osteogenic media
for 6 days (transfected cells and untransfected control cells,
UNTR/Diff) or in untransfected cells incubated in propagation
media (UNTR/Undiff). Data are representative of two indepen-
dent experiments performed in triplicate. (mean+/2stdev).
Found at: doi:10.1371/journal.pone.0005605.s001 (3.16 MB TIF)
Figure S2 Inhibition of miR-148b, -27a and -489 does not
influence adipogenesis in hMSC. hMSC were transfected with
miRNA inhibitors or control molecules ( all at 25 nM).
Transfected cells were switched to differentiation 24 hr after
transfection. Adipogenesis was determined as a fraction (%) of
adipocytes in cultures. Data are representative of three indepen-
dent experiments performed in triplicate. (mean+/2stdev).
Found at: doi:10.1371/journal.pone.0005605.s002 (1.55 MB TIF)
Figure S3 Alteration in miRNA activity results in increase of
osteogenesis as measured by number of AP-positive cells. (A–G)
Effect of alteration in miRNA activity results in increase of
osteogenesis as measured by number of AP-positive cells in hMSC
cultures. UNTR/Diff - untransfected differentiated cells, UNTR/
Prop - untransfected undifferentiated cells, IC1,- cells transfected
with Inhibitor Control Molecule 1, MC1,- cells transfected with
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PLoS ONE | www.plosone.org 7 May 2009 | Volume 4 | Issue 5 | e5605Mimic Control Molecule 1, i27a - cells transfected with Inhibitor
for miR27a, i489 - cells transfected with Inhibitor for miR489,
m148b - cells transfected with mimic for miR148b. (H)
Quantitative analysis of results obtained in experiments partially
depicted in (A–F).
Found at: doi:10.1371/journal.pone.0005605.s003 (9.74 MB TIF)
Figure S4 Alteration in miRNA activity produced similar results
in hMSCs from two different donors and in human adult stem cells
originated from adipose tissue. (A) Results obtained on AP activity
of hMSCs from two different donors Alteration in miRNA activity
in human adult stem cells derived from adipogenic tissue results in
increase of AP activity (B) and up-regulation of SPP1 expression
(C). Cells were treated as described in Supplemental Figure 2
legend are representative of three independent experiments
performed in triplicate. (mean+/2stdev).
Found at: doi:10.1371/journal.pone.0005605.s004 (8.66 MB TIF)
Figure S5 Alteration of the miRNAs activities transfection
rescues osteogenic potential in transfected hMSC with high
passage number. Transfection with miRNA inhibitors and mimics
restores differentiation in overpropagated hMSC incubated in
propagation (A) or differentiation (B) media as measured by SPP1
(osteopontin) expression. Data are representative of three inde-
pendent experiments performed in triplicate. (mean+/2stdev).
Found at: doi:10.1371/journal.pone.0005605.s005 (3.16 MB TIF)
Figure S6 Effect of on osteogenesis miR-489 and -27a is not
mediated by repression of CHRD or PEX7. (A) RT-PCR-based
study of gene expression demonstrated that the expression of
PEX7 but not CHRD mRNA is regulated by miR-489 and -27a.
(A) siRNA-mediated knockdown of PEX7 did not produce a
significant decrease of AP activity in hMSC under differentiation
conditions. Data shown represents two independent transfection
experiments performed in duplicate (A) or triplicate (B) (mean+/
2SD).
Found at: doi:10.1371/journal.pone.0005605.s006 (3.16 MB TIF)
Figure S7 GCA and PEX7 39UTR reporter activity is regulated
by miR-489 and -27a. HT1080 cells were transfected with Mimic
Control molecule 1 (mc1, 12.5 nM) or with a combination of
inhibitors for miR-27 and -489 (i27a+i489, 6.25 nM each) and
with 39UTR reporter constructs as imdicated. Transfected cells
were incubated for 48 and then harvested and processed as
described in Materials and Methods. Data shown represents 3
individual transfections (mean+/2SD). **- p,0.05, Student’s ttest
p value between treated cells and corresponding control group.
Found at: doi:10.1371/journal.pone.0005605.s007 (0.87 MB TIF)
Figure S8 Uptake of fluorescently labeled Inhibitor Control
Molecule 1 or Mimic Control Molecule 1 by hMSCs. Cells were
transfected with Dy549-labeled MimicControl molecule 1 (C, D)
or Inhibitor Control Molecule 1 (A,B) as described in Materials
and Methods. Live cells were stained with Hoechst 33342 nuclear
dye (A,C) 24 hr after transfection and photographed.
Found at: doi:10.1371/journal.pone.0005605.s008 (3.14 MB TIF)
Figure S9 Osteogenic differentiation of hMSCs (A) Activation of
AP in hMSCs incubated in osteogenic media for 6 days. Cells were
incubated either in propagation media (Propagation) or in
osteogenic media (Differentiation). (B) Increase in the number of
AP-positive cells in differentiated cultures of hMSC harvested at 6
days of incubation in osteogenic media. Cells were incubated
either in propagation media (Propagation) or in osteogenic media
(Differentiation). (C) Upregulation of SPP1 expression in hMSCs
incubated in osteogenic media for 6 days. Cells were incubated
either in propagation media (Propagation) or in osteogenic media
(Differentiation). (D) Effect of control miRNA inhibitor and mimic
on differentiation of hMSCs. Cells were transfected with
MimicControl molecule 1 (MC1) or Inhibitor Control Molecule
1 (IC1) as indicated. Transfected cells were switched to
differentiation 24 hr after transfection. AP activity was measured
in hMSCs incubated in osteogenic media for 6 days (MC1, IC1
and UNTR/Diff - untransfected control cells) or in untransfected
cells incubated in propagation media (UNTR/Undiff) . Cells were
incubated either in propagation media (Propagation) or in
osteogenic media (Differentiation). Data are representative of
three independent experiments performed in triplicate. (mean+/
2stdev).
Found at: doi:10.1371/journal.pone.0005605.s009 (2.89 MB TIF)
Table S1 Expression of miR-148b, -27a and -489 in hMSCs
under propagation and differentiation conditions.
Found at: doi:10.1371/journal.pone.0005605.s010 (0.05 MB
DOC)
Table S2 Genes that are predicted as a target for miR-148b, 27a
and 489 and involved into skeletal development.
Found at: doi:10.1371/journal.pone.0005605.s011 (0.08 MB
DOC)
Table S3 Genes that are predicted as common targets for miR-
27a and -489.
Found at: doi:10.1371/journal.pone.0005605.s012 (0.09 MB
DOC)
Table S4 Genomic coordinates of the fragments cloned into
39UTR reporter constructs.
Found at: doi:10.1371/journal.pone.0005605.s013 (0.04 MB
DOC)
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